Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial (Q39368191)

11 September 2017

title

Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55715

9 April 2022

1 reference

V. Mani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55715

9 April 2022

G. Lloyd

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55715

9 April 2022

F. H. Green

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55715

9 April 2022

H. Fox

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55715

9 April 2022

L. A. Turnberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A55715

9 April 2022

language of work or name

English

0 references

publication date

1 February 1976

1 reference

11 September 2017

28 February 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=55715

9 April 2022

number of pages

1 reference

full work available at URL

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0140673676914719?httpAccept=text/xml

1 reference

10.1016/S0140-6736(76)91471-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91471-9

https://api.elsevier.com/content/article/PII:S0140673676914719?httpAccept=text/plain

9 April 2022

1 reference

10.1016/S0140-6736(76)91471-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(76)91471-9

9 April 2022

1 reference

11 September 2017

1 reference

11 September 2017

issue

7957

1 reference

11 September 2017

page(s)

439-441

1 reference

Disodium cromoglycate in the treatment of chronic proctitis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991471-9

7 January 2021

Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991471-9

7 January 2021

Cromoglycate in aphthous stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991471-9

7 January 2021

Disodium cromoglycate in gastrointestinal protein intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991471-9

7 January 2021

Mast cells and immunoglobulin E in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991471-9

7 January 2021

Immunoglobulin E in rectal mucosa of patients with proctitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991471-9

7 January 2021

10.1016/S0140-6736(76)91471-9

Identifiers

DOI

1 reference

11 September 2017

1 reference